| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 6 |
| 1 | ACETAMINOPHEN 500MG | 6 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 6 |
| 3 | PAIN RELIEVER | 6 |
| 4 | ATEZOLIZUMAB | 2 |
| 5 | BEVACIZUMAB-ADCD | 2 |
| 6 | TAFAMIDIS MEGLUMINE | 2 |
| 7 | ACALABRUTINIB | 1 |
| 8 | ANTACID | 1 |
| 9 | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEVACIZUMAB-ADCD | 2 | 0.0099 |
| 1 | SELADELPAR LYSINE | 1 | 0.0036 |
| 2 | HEMIN | 1 | 0.0017 |
| 3 | ENSIFENTRINE | 1 | 0.0005 |
| 4 | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | 1 | 0.0005 |
| 5 | TAFAMIDIS MEGLUMINE | 2 | 0.0004 |
| 6 | IVABRADINE | 1 | 0.0001 |
| 7 | POLATUZUMAB VEDOTIN | 1 | 0.0001 |
| 8 | ACALABRUTINIB | 1 | 0.0001 |
| 9 | VELPATASVIR AND SOFOSBUVIR | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 1 | Antimalarial [EPC] | 1 | 0.0001 |
| 2 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 3 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 4 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |
| 5 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 7 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Complement Inhibitor [EPC] | 1 | 0.0000 |